Technion - Israel Institute of Technology: Why Some Cancer Patients Respond to Immunotherapy While Others Don't May Depend on What Happens Early in Treatment
September 17, 2026
September 17, 2026
HAIFA, Israel, Sept. 17 -- The Technion - Israel Institute of Technology issued the following news:
* * *
Why Some Cancer Patients Respond to Immunotherapy While Others Don't May Depend on What Happens Early in Treatment
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients apart before . . .
* * *
Why Some Cancer Patients Respond to Immunotherapy While Others Don't May Depend on What Happens Early in Treatment
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients apart before . . .